{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-067520","form_type":"8-K","ticker":"OKUR","cik":"0001637715","company_name":"OnKure Therapeutics, Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.951010+00:00","generated_at":"2026-06-18T05:32:10.788158+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Reneo Pharmaceuticals says SVB exposure immaterial; accounts hold minimal cash","bullets":["Company maintains operating accounts at Silicon Valley Bank with minimal cash relative to total cash, cash equivalents and investments.","Believes any loss from SVB receivership is immaterial to its financial position.","No further details on total cash balance or contingency plans disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-067520","json":"https://secwatch.observer/filing/0001193125-23-067520.json","markdown":"https://secwatch.observer/filing/0001193125-23-067520.md","text":"https://secwatch.observer/filing/0001193125-23-067520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/0001193125-23-067520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637715/000119312523067520/d481495d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:32:10.788158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}